About ClonOrgan

About ClonOrgan

Company Profile
China's Leading Xenotransplantation Enterprise

ClonOrgan Biotechnology Co., Ltd. (hereinafter referred to as "ClonOrgan") is China's leading xenotransplantation enterprise, co-founded by the national-level talent team of Prof. Dengke Pan and Prof. Shaoping Deng. ClonOrgan is long-term dedicated to the in-depth R&D of xenotransplantation donor pigs, cultivating China's largest herd of gene-edited low-immunogenicity donor pigs, developing therapeutic technologies using transplantable pig kidneys, livers, hearts, skin, red blood cells, and more, achieving a breakthrough in the entire industry chain technology from gene-edited pigs to the clinical application.

China's Leading Xenotransplantation Enterprise
Corporate History
2005
2005

Professor Dengke Pan

Developed China's first somatic cell cloned pig

Awarded the National Science and Technology Progress Award (Second Prize)

2010
2010

Dengke Pan team

Developed China's first GTKO (α1,3-galactosyltransferase knockout) pig

2018
2018

Established ClonOrgan Biotechnology

Developed over 10 gene-edited pig lines

2020
2020

Established China's first gene-edited miniature pig breeding base

(Neijiang)

2022
2022

Established China's first ultra-clean DPF (Designated Pathogen-Free) breeding center for gene-edited miniature pigs (Neijiang) 

2023
2023

kidney transplantation into brain-dead human recipients using gene-edited pigs

2024
2024

Completed world's first

liver xenotransplantation from a gene-edited pig into a brain-dead human recipient

2025
2025

kidney transplantation into a patient, The first case in Asia of kidney transplantation into apatient, with post-transplant survival exceeding 261 days.

2027
2027

Projected clinical trial approval for gene-edited pig kidney xenotransplantation

Qualifications and Honors
  • Demonstration Base for Medical Pig Disease Prevention and Control (National Pig Technology Innovation Center, 2023)

  • Medical Pig Xenotransplantation Cooperation Base

    (National Major Scientific and Technological Infrastructure – Model Animal (Pig), July 2023)

  • Xenotransplantation and Regeneration Key Laboratory of Sichuan Province

  • "Specialized, Refined, Unique, and Innovative" SME of Sichuan Province

  • High-Tech Enterprise

  • Vice Chair Unit of Sichuan Provincial Association for Laboratory Animal Science

  • ClonOrgan–Sichuan Agricultural University Industry–University–Research Joint Laboratory (Chengdu)

  • Public Technology Platform for Gene Editing and Somatic Cell Cloning(Chengdu High-tech Zone)

  • Gene Editing and Large Animal Human Disease Model Innovation Service Platform(Chengdu High-tech Zone)

  • Seed-Stage Eaglet Enterprise(Chengdu High-tech Zone)

  • High-Level "Four-Talent" Enterprise(Chengdu High-tech Zone)

资质证书

资质证书

资质证书

资质证书

资质证书

资质证书

资质证书

资质证书

资质证书

资质证书

Corporate Culture
  • Mission

    To care for life and contribute to human health and longevity!

  • Goal

    To become a leading enterprise in the global xenotransplantation donor pig industry.

  • Values

    Adhering to passion, never forget the original aspiration, conduct business with kindness.

  • Motto

    Innovation and Pragmatism, Rigor and Efficiency, Striving and Dedication.

Scientific Committee
  • Professor Leo Hans Bühler

    Professor Leo Hans Bühler

  • Professor Shaoping Deng

    Professor Shaoping Deng

  • Professor Dengke Pan

    Professor Dengke Pan

  • Professor Gang Chen

    Professor Gang Chen

  • Professor Yi Wang

    Professor Yi Wang

  • Professor Hidetaka Hara

    Professor Hidetaka Hara

Professor Leo Hans Bühler
Professor Leo Hans Bühler
M.D., Ph.D., Chair of the Scientific Committee

· Former President, International Xenotransplantation Association (IXA)

· Editor-in-Chief of Xenotransplantation (since 2012)

· Director, Department of Surgical Research, University and Hospital of Fribourg, Switzerland

· Author of 270+ Peer-Reviewed Papers and 10+ Academic Books

· Expert in Xenotransplantation Immunology and Ethical Regulation

Professor Shaoping Deng
Professor Shaoping Deng
M.D., Chief Physician, Doctoral Supervisor, Vice-Chair of the Scientific Committee

· Council Member, International Xenotransplantation Association (IXA)

· Nearly Two Decades of Research and Clinical Practice at the University of Pennsylvania and Massachusetts General Hospital (Harvard)

· Author of 150+ SCI-Indexed Papers; Principal Investigator on Multiple National Key R&D Programs

· Former President, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital 

· Expert in Organ Transplantation and Immune Tolerance Induction 


Professor Dengke Pan
Professor Dengke Pan
Founder & Chair, ClonOrgan Biotech

人物简介  

       潘登科,二级研究员,博士生导师,国家“万人计划”科技创业领军人才,异种移植与再生四川省重点实验室主任,四川大学华西医院特聘研究员。中华医学会器官移植学分会异种移植学组副组长,中科奥格生物创始人、董事长。

       2005年培育中国首例体细胞克隆猪,2010年培育中国首例GTKO基因敲除猪。2018年创立中科奥格生物,培育10余种基因编辑供体猪种系,建立超洁净设施培育医用级DPF临床用猪。合作完成国际首例基因编辑猪肝脏、肺脏到人体的亚临床研究。合作开展亚洲首例基因编辑猪肾脏到患者的临床研究,猪肾脏在患者体内工作261天,是目前国际上猪肾脏工作第二长纪录。合作开展国际首例基因编辑猪肝脏体外灌注治疗肝衰竭患者获成功,经过66小时持续治疗,患者状况良好,主要肝功能指标显著改善,为未来临床终末期肝病治疗及肝移植术前桥接治疗提供全新策略。获国家科技进步奖二等奖2项,大北农科技奖二等奖1项。授权发明专利10项。在Nature medicine、PNAS、Cell Reports Medicine、Xenotransplantation等杂志发表论文120多篇。


教育经历 

2002.09 -2005.06   中国农业大学 动物遗传育种与繁殖专业    博士

1999.09 -2002.06   甘肃农业大学 动物遗传育种与繁殖专业    硕士

1990.09 -1994.06   西北民族大学 畜牧专业   学士


科研经历

2026.03至今   四川大学华西医院特聘研究员

2025.08至今   异种移植与再生四川省重点实验室主任

2018.10-2024. 01   四川省医学科学院·四川省人民医院器官移植研究所副所长,电子科技大学医学院生物医学工程专业博士生导师

2005.07-2018.10    中国农业科学院北京畜牧兽医研究所,副研究员,基因与细胞工程专业,硕士生导师


社会任职

中华医学会器官移植学分会异种移植学组           副组长

中国医药生物技术协会疾病模型分会                    副主任委员

中国实验动物学会实验小型猪专业委员会           副主任委员

四川省医学会器官移植专业委员会                        常务委员

四川省实验动物学会                                                   副理事长

四川省实验动物学会医用猪专业委员会               主任委员


荣誉奖励

2010年   国家科技进步奖二等奖   牛和猪体细胞克隆研究及应用 

2017年   国家科技进步奖二等奖   肝移植新技术—脾窝异位辅助性肝移植的建立与应用

2024年   大北农科技奖二等奖   用于异种器官移植临床研究的六基因供体猪


科研项目

      承担国家科技重大专项、国家重点研发项目、国家自然科学基金等课题20余项。近五年主要科研项目如下:

1.国家科技重大专项新型组织方式项目: 医用级供体猪培育及异种器官移植临床转化技术研究,2025-2028年,项目负责人;

2.国家重点研发计划项目:高适配性基因编辑供体猪的研发,2025-2027年,课题负责人;

3.国家自然科学基金重大项目:心脏异种移植生物安全性保障策略和评估方案研究,2021-2025年,课题负责人;

4.国家重点研发计划项目:基因修饰巴马小型猪用于肾脏、肝脏和胰岛的供体,2017-2021年,课题负责人。



代表论文(*为通讯作者, #为第一作者)

1. Li  Xin,Du Lijuan,Wan Zihui, Jin Zhiren,Peng Yuanhao,Fan Yongliang,Ke Cuncun,Ma Yonghe, Han Haitang,Yu Shuyang,Cao Gengsheng,Huang Tian,Pan-Hammarströme Qiang, Hammarströme Lennart,Li Ning,Li Mingzhou,Zhang Ran*,Du Xuguang*,Pan Dengke*,Zhao Yaofeng*. FcγRIIB functions as an IgG transporter in the mammary gland. PNAS2026 基因编辑猪模型 

2. Tao Kaishan#, Ling Yuwei#, Zhang Xuan#, Yang Zhaoxu#, Zhang Hongtao, Yue Shuqiang, Yang Yanling, Song Wenjie, Wang Desheng, Liu Zhengcai, Li Haimin, Chen Yong, Ding Rui, Li Lin, Li Min, Lin Zhibin, Xu Hao, Wei Dan, Zhang Hong, Duan Juanli, Zhuang Ran, Long Enwu, Zhou Liang, Pan Dengke*, Dou Kefeng*, Wang Lin*. Immune cell landscape in a human decedent receiving a pig liver xenograft. Nature Medicine2025 基因编辑猪肝脏到人体的免疫机制研究

3. Peng Wen Chuan, Zhai Yuan Yuan, Li Meng Ke, Zhang Chu Xiong, Du Jia Xiang, Jiang Yan Yan, Pan DengKe*, Wu Jiang Wei*. Evaluation of Physiological Integrity in Six-Gene-Edited Bama Miniature Pigs as a Model for Xenotransplantation. Biotechnology Journal, 2025 六基因编辑猪的生理指标评价  

4. Huo Xueyun#, Sun Xianhui#, Xing Xiangyang#, Lu Jing, Zhang Jingjing, Jiang Yanyan, Zhu Xiao, Li Changlong, Lv Jianyi, Guo Meng, Cao Lixue , Liu Xin, Chen Zhenwen*, Pan Dengke*, He Shunmin*, Zhang Chen*, Du Xiaoyan*. Genome-wide Genetic Mutations Accumulated in Pigs Genome edited for Xenotransplantation and Their Filial Generation. Genomics, Proteomics & Bioinformatics2025 基因编辑引起的突变检测和遗传研究

5. Huai Guoli, Wang Yong, Du Jiaxiang, Cheng Zhenhui, Xie Yuxuan, Zhou Jia, Tang Hongmei, Jiang Yanyan, Xing Xiangyang, Deng Shaoping, Pan Dengke*. The generation and evaluation of TKO/hCD55/hTM/hEPCR gene-modified pigs for clinical organ xenotransplantation. Frontier in Immunology, 2025 六基因编辑供体猪的培育 

6. Wang Yi*#, Chen Gang#Pan Dengke#(co-first authors), Hui Guo,Hongtao Jiang,Jianli Wang, Hao Feng,Songzhe He,Jiaxiang Du,Man Zhang, Tao Li, Yong Wang,Hang Yu, Huiling Gan,Quan Wen,Zhian Song, Desheng Li,Yifan Yu,Huanliang Wang,Bing Li,Yong You,Shen Zhou,Mingfa Wang,Lili Liu,Liang Xu,Meng Yang,Hua Pei,Kang Zhang*,Zhonghua K Chen*. Pig-to-human kidney xenotransplants using genetically modified minipigs. Cell Reports Medicine2024 中国首例猪肾移植到人体的研究

7. Li Tao, Hao Feng, Du Jiaxiang, Xia Qiangbing, Cooper David, Jiang Hongtao, He Songzhe, Pan Dengke*, Chen Gang*, Wang Yi*. Serum antibody binding and cytotoxicity to pig cells in chinese subjects: relevance to clinical renal xenotransplantation. Frontiers in Immunology2022 异种移植临床基础研究

8. Pan Dengke, Liu Ting, Lei Tiantian, Zhu Huibin, Wang Yi, Deng Shaoping*, Progress in multiple genetically modified minipigs for xenotransplantation in China. 

Xenotransplantation2019 中国异种移植供体猪研究

9. Ji Huili, Long Chuan, Feng Chong, Shi Ningning, Jiang Yingdi, Zeng Guomin, Li Xirui, Wu Jingjing, Lu Lin, Lu Shengsheng*, Pan Dengke*, Generation of chimeric minipigs by aggregating 4- to 8-cell-stage blastomeres from somatic cell nuclear transfer with the tracing of enhanced green fluorescent protein. Xenotransplantation2017 封面论文,嵌合体猪10.Pan Dengke,Zhang Yunhai,Sun Xiuzhu,Zhang Jian,Li Xuyang,Gu Zhiliang,Dai Yunping, Wu Changxin*,Li Ning*,Cloned pigs derive from somatic cell nuclear transfer embryos cultured in vitro at low oxygen tension.Chinese Science Bulletin, 2006中国首例体

细胞克隆猪

Professor Gang Chen
Professor Gang Chen
M.D., Distinguished Professor (National Second-Level, China), Chief Physician, Doctoral Supervisor

· Deputy Director, Key Laboratory of Organ Transplantation (Ministry of Education, National Health Commission & Chinese Academy of Medical Sciences)

· Achieved a record-setting breakthrough in porcine kidney-to-primate transplantation in Asia

· Director, Institute of Organ Transplantation, Tongji Hospital, Huazhong University of Science and Technology

· Deputy Editor-in-Chief, Chinese Journal of Organ Transplantation

· Expert in Rejection Management and Immune Risk Control in Xenotransplantation 


Professor Yi Wang
Professor Yi Wang
M.D., Distinguished Professor (National Second-Level, China), Senior Chief Physician (National First-Level, China), Doctoral Supervisor

· Director, Institute of Transplantation Medicine, Second Affiliated Hospital of Hainan Medical University

· Director, National Key Laboratory for Tropical Disease Prevention and Control (National Health Commission, China)

· Chair, Dialysis and Transplantation Branch, Chinese Society of Biomedical Engineering (CSBME)

· Dedicated to bringing transplantation immunology achievements into clinical practice in China

· Expert in Clinical Translation and Applications of Xenotransplantation


Professor Hidetaka Hara
Professor Hidetaka Hara
M.D., Ph.D.

· Professor, Institute of Transplantation Medicine, Second Affiliated Hospital of Hainan Medical University

· Council Member, International Xenotransplantation Association (IXA, 2023–2025)

· Editorial Board Member, Xenotransplantation; reviewer for The Lancet and Nature Communications

· Expert in Preclinical Large-Animal Transplantation Surgery

· Expert in Xenotransplantation and Immunobiology